美国食品和药物管理局对医疗器械的监管和批准:1976年至2020年
Jonathan J Darrow1, Jerry Avorn1, Aaron S Kesselheim1
1Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
美国食品和药物管理局 (FDA) 监管医疗设备,以确保益处超过风险. 在过去的45年里, 监管发展了新的途径, 增加了行业资金, 但患者安全问题依然存在.
科学领域:
- 医疗器械法规
- 监管事务
- 公共卫生政策
背景情况:
- 美国法律要求对高风险的医疗器械进行市场前测试,对中等风险的医疗器械进行评估.
- 美国食品和药物管理局 (FDA) 将证据生成与促进获取和创新进行平衡.
- 自1976年以来,医疗器械的监管体系发生了重大变化.
更多相关视频
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
07:43Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
相关概念视频
Drug Regulation
FDA Approved Drugs: Changes to Approved Drugs
Clinical Trials: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Control Governance: Regulatory Bodies and Their Impact
Clinical Trials
There are four phases in a clinical trial. A phase one...
